- an injectable medicine
Arleevskaya M, Takha E, Petrov S, et al
Wang, L., Cao, Z., Wang, Z., Guo, J
The clinical outcomes of interest were excessive daytime sleepiness, dissociative manifestations of REM sleep: cataplexy, sleep paralysis, hypnagogic hallucinations, and early REM sleep (naps with REM sleep, SOREMP)
While these medications effectively decrease acid levels, they fail to address the underlying mechanical dysfunction allowing reflux to occur
The compounding difference Compounded tirzepatide and compounded semaglutide are prepared by compounding pharmacies and may contain different excipients (inactive ingredients), different concentrations, and different purity profiles than FDA-approved formulations